Skip to main content

Author: AUFTAU

TAU Wins 3M Grant to Accelerate COVID-19 Vaccine Development

Grantee Professor Jonathan Gershoni aims to block the coronavirus by targeting its most vulnerable spot

Science-based technology company 3M has awarded a significant philanthropic research grant of $400,000 (1.36 million NIS) to the Shmunis School of Biomedicine and Cancer Research at Tel Aviv University to advance scientific knowledge in the global response to the COVID-19 pandemic. The grant from 3M, which bases its Israel operations in Herzliya, is part of a $5 million initiative to support research programs with a focus on treatments and vaccine development for COVID-19 at leading educational establishments around the world. TAU secured the funding through an international competitive process; this reflects the high esteem in which the University’s scientific research programs are held. The grant was disbursed via 3M’s grant-making partner, GlobalGiving, to ensure thorough vetting, due diligence and reporting. The research project is being led by Professor Jonathan Gershoni, a renowned expert in viral pathogens, who said: “Publication of the SARS CoV2 genome on January 9, 2020, launched the race for a COVID-19 vaccine. Tens of vaccine candidates have already entered clinical trials, the leaders of which are actively recruiting thousands of volunteers worldwide for phase III efficacy trials. All these efforts use the viral spike protein as their vaccine’s active ingredient. This relatively large protein is made up of 1200 amino acids arranged in groups of three, decorating the virus with a crown-like appearance. “The spike protein presents many targets that have evolved to confuse and distract our immune system and to steer us away from the virus’ most vulnerable soft spot, its receptor-binding motif (RBM). In order for the virus to successfully infect us and cause COVID- 19, it must first latch onto a unique protein, the ACE2 receptor, which is present on the surface of our lung cells. For this, the viral RBM, a tiny but highly complex structure, must detect ACE2, bind to it and mediate infection. A vaccine that exclusively targets the RBM should be extremely potent in affording maximal protection against SARS CoV2 by stimulating our immune system in the most efficient and cost-effective way. “We have developed a novel patented technology to ‘surgically’ isolate the RBM from the rest of the spike protein. This grant from 3M will significantly enhance our efforts to produce a highly focused, potent and especially safe vaccine for COVID 19,” he added. Prof. Gershoni’s Lab team (Photographer: Moshe Bedarshi) This study is anchored in more than 30 years of research on the interaction of RNA viruses with their receptors and the immune response against them, noted Professor Tal Pupko, Head of the Shmunis School at TAU. “The 3M grant will dramatically accelerate the pace of research for overcoming COVID-19,” said Professor Pupko, adding that Tel Aviv University was particularly proud to be included in this important global initiative by 3M. “Science is at the heart of 3M and we are committed to advancing the rapid study of this virus as part of our continued effort to combat the COVID-19 pandemic,” said Isabelle Zadikov-Carp, 3M Israel Country Leader. “It’s important that 3M holds true to its core values by supporting our communities and improving lives. We hope that the grant to TAU will facilitate the development of an effective vaccine and we will be keenly following the progress and outcomes of Professor Gershoni’s research with interest.” Featured image: Professor Jonathan Gershoni (Photographer: Moshe Bedarshi)

TAU Inaugurates Shmunis School of Biomedicine and Cancer Research

School is funded with a generous gift from the Shmunis family for research and improved treatments for cancer, COVID-19, and other diseases Tel Aviv University inaugurated the Shmunis School of Biomedicine and Cancer Research, in the presence of Israel’s Minister of Science and Technology Izhar Shay and benefactors Vlad and Sana Shmunis, online, via RingCentral. The new School, part of the George S. Wise Faculty of Life Sciences will enable a leap in biomedical research.  The School’s 300 researchers, students and staff in the fields of cancer research, cancer immunity, bioinformatics, microbiology, biotechnology, and more, will work to identify mechanisms that drive cancer and other diseases. Moreover, they will develop new pharmaceuticals and improve patients’ quality of life. This will be achieved through multidisciplinary collaborations and novel research approaches, such as single cell sequencing and bioinformatics. Vlad and Sana Shmunis expressed hope that their gift will help strengthen Israel’s standing as a global leader in cancer and molecular biomedical research. “In supporting TAU, we firmly believe that we have found an ideal partner to move the needle towards curing cancer and other terrible diseases,” said Vlad Shmunis, Chief Executive Officer and Founder of RingCentral, Inc. “Cancer is a disease that has unfortunately touched our family and far too many other families.  We hope that our gift to TAU will … improve the lives of people in Israel and around the world.” The new partnership will enable the University to recruit the finest researchers and award the annual Shmunis Fellowships to exceptional PhD students. The School will also collaborate with leading academic institutions and host Shmunis Visiting Scholars and international conferences.

Recent Shmunis School achievements:

  • The Gershoni Lab was awarded a US patent for a novel vaccine against the coronavirus
  • The Stern Lab‘s genetic sequencing of the coronavirus tracked the spread of COVID-19 in Israel
  • The Ehrlic Lab is developing virus-based immunotherapies for cancer ​
  • The Lederkremer Lab developed a therapeutic approach for Huntington’s disease, for which no treatment exists
“I am grateful to the Shmunis family for their important and generous gift,” said Prof. Ariel Porat, President of Tel Aviv University. “Meeting high standards of other renowned centers for cancer research around the globe, the School will be a hub for the brightest Israeli and international researchers to join as faculty.” This is the Shmunis family’s second major donation to the University. They founded the Shmunis Family Anthropology Institute in 2018 dedicated to the study of the ancient past. The Institute conducts numerous cutting-edge research projects in anthropology and archaeology on campus, helping to shed light on the origins of humankind. Featured image: Prof. Ariel Porat, TAU President, and Prof. Tal Pupko, head of the Shmunis School, at the Shmunis School Inauguration Ceremony. Photo: Chen Galili.

How the parents’ environment impacts the lives of their offspring

Three rules that dictate transgenerational epigenetic inheritance in worms – independently of changes in DNA sequences.

Researchers at Tel Aviv University have discovered three rules that dictate epigenetic inheritance – meaning transgenerational inheritance through means other than changes in DNA sequences. Published today in the leading scientific journal Cell, the study was led by Prof. Oded Rechavi and his research student Dr. Leah Houri-Zeevi of the Department of Neurobiology at the Faculty of Life Sciences and the Sagol School of Neuroscience at Tel Aviv University.

Most experiences we acquire in our lifetime will not be passed on to our descendants. For example, our workout in the gym today will not make our children stronger. However, studies conducted in recent years on epigenetic inheritance in worms challenge our traditional concepts regarding the limits of inheritance and evolution, indicating that some acquired traits are in fact passed on to subsequent generations. Prof. Rechavi explains: “Epigenetic inheritance of responses to the environment occurs independently of changes to the DNA sequence, through other inherited molecules. In many organisms, responses to environmental changes, such as stress, involve small RNA molecules that silence or block the expression of certain genes.” In recent years, research on C. elegans worms – an important and widely used model animal – has shown that small RNA molecules can be transmitted to subsequent generations, thereby passing on certain traits.

In previous research projects, Prof. Rechavi discovered that worms transfer to their offspring small RNA molecules containing information on the parent’s environment, such as viral infections, nutrition, and even brain activity, thereby contributing to the survival of subsequent generations. In the current study, Prof. Rechavi and his team tried to understand whether transgenerational epigenetic inheritance via small RNA molecules is governed by specific rules, or alternately, occurs passively and randomly.

According to Prof. Rechavi, “C. elegans is the preferred model organism for research on transgenerational epigenetic inheritance, for several  reasons: Its generation time is three and a half days, allowing us to study many generations in a short period of time; every worm produces hundreds of descendants, providing strong statistical validity; environmental exposure can be fully controlled; and each worm fertilizes itself, so that differences in DNA are almost completely neutralized.”

Dr. Houri-Zeevi explains that “Many laboratories have noted that at the level of a population epigenetic inheritance through small RNA endures for about three to five generations in worms. In a previous study, we discovered a mechanism that controls the duration of the inheritance, proving, in effect, that this type of inheritance is a regulated process. But still the question remains: Why are some worms strongly affected by their ancestor’s environmental responses, while others do not inherit the epigenetic effect at all – despite the fact that all offspring are almost identical genetically. This partial inheritance has been known for some time, but how epigenetic material is distributed among the offspring remained a mystery. We wanted to find out whether there was any pattern in the inheritance, that might explain and allow us to predict who would inherit the epigenetic features – and for how long.”

The researchers used a genetically engineered worm carrying a gene that produces a fluorescent protein – making the worm itself glow under fluorescent light. The researchers then initiated a heritable small RNA silencing response against the fluorescent gene and observed which descendants had inherited the silencing response and stopped glowing, and which descendants ‘forgot’ the parental response and started expressing the fluorescent gene once again after several generations. Dr. Houri-Zeevi repeated this process over and over again, in an attempt to understand the rules governing the epigenetic effect. Altogether she examined dozens of worms lineages, including more than 20,000 individual worms. But the most challenging part, according to Prof. Rechavi, was deciphering the different inheritance patterns and understanding the rules behind them.

Ultimately, through in-depth investigation of the inheritance mechanism, the researchers discovered three laws that can explain and even enable the prediction of who inherits the epigenetic information:

  • First law: Inheritance is uniform in worms descending from the same mother – namely worms of the same lineage. The researchers were surprised to learn that differences in inheritance observed in previous studies were in fact ‘concealed’ due to the method of examining whole worm populations rather than distinct lineages.
  • Second law: Inheritance is very different in worms derived from different mothers, even though the mothers themselves are supposedly identical, because the worm fertilizes itself. The researchers characterized the mechanism that creates the differences between mothers who are genetically identical and found that differences between descendants stem from varying ‘internal states’ randomly adopted by the mothers. Essentially, the mother’s internal state, the level of activity of the inheritance mechanism in each mother, determines the duration of inheritance, and thus the fate of subsequent generations.
  • Third law: The longer the duration of the epigenetic inheritance – namely, the greater the number of generations in a specific lineage who inherits the trait – the greater the probability that it will continue on to the next generation as well, “in something like transgenerational momentum, resembling the ‘Hot Hand’ rule in basketball.”

According to Prof. Rechavi, we do not yet know whether the exact same transgenerational epigenetic inheritance mechanism exists in humans as well: “We hope that the mechanism we have discovered exists in other organisms as well, but we’ll just have to be patient. We must remember that genetic research also began with Friar Gregor Mendel’s observations in peas, and today we use Mendel’s laws to predict whether our children will have smooth or curly hair.”

“The idea of acquired traits passed on to descendants is as old as it is outrageous. Even before Darwin and Lamarck, the ancient Greeks argued about it, and it seems to be incompatible with genetic inheritance through DNA,” adds Prof. Rechavi. “The worms changed the rules by showing us that inheritance outside the genetic sequence does exist, via small RNA molecules, enabling parents to prepare their offspring for the difficulties they have encountered in their lifetime. From one study to the next we shed light on the molecular mechanisms and mysterious dynamics of epigenetic inheritance, with the present study providing laws and introducing some ‘order into the chaos’.”

Does our Brain like risk?

A new study attempts to find out whether our brains are prone to over caution or to underestimating risk

A new Tel Aviv University study examined the brain’s reactions in conditions of uncertainty and stressful conflict in an environment of risks and opportunities. The researchers identified the areas of the brain responsible for the delicate balance between desiring gain and avoiding potential loss along the way.

The study was led by Tel Aviv University researchers Prof. Talma Hendler, Prof. Itzhak Fried, Dr. Tomer Gazit, and Dr. Tal Gonen from the Sackler Faculty of Medicine, the School of Psychological Sciences and the Sagol School of Neuroscience, along with researchers from the the Tel Aviv Sourasky Medical Center (Ichilov) and the University of California, Los Angeles School of Medicine. The study was published in July 2020 in the prestigious journal Nature Communications.

Prof. Hendler explains that in order to detect reactions in the depths of the brain, the study was performed among a unique population of epilepsy patients who had electrodes inserted into their brains for testing prior to surgery to remove the area of the brain causing epileptic seizures. Patients were asked to play a computer game that included risks and opportunities, and the electrodes allowed the researchers to record, with a high level of accuracy, neural activity in different areas of the brain associated with decision-making, emotion and memory.

Your brain suggests – play it safe

Throughout the game, the researchers recorded the electrical activity in the subjects’ nerve cells immediately after they won or lost money. The subjects were asked to try to collect coins while taking the risk of losing money from their pool. It was found that the neurons in the area of ​​the inner prefrontal cortex responded much more to loss (punishment) than to the gaining (reward) of coins.

Moreover, the researchers found that the avoidance of risk-taking in the players’ next move was affected mainly by post-loss activity in the area of the hippocampus, which is associated with learning and memory, but also with anxiety. This finding demonstrates the close relationship between memory processes and decision-making when risk is present (stressful situations). That is, the loss is encoded in the hippocampus (the region of the brain associated with ​​memory), and the participant operating in a high-risk stressful situation preferred to be cautious and avoid winning the coins (forfeiting the gain).

The experience of winning, however, was not encoded in the memory in a way that influenced the choice of future behavior in conditions of uncertainty. An interesting point is that this phenomenon was found only when the subject was the once influencing the result of the game, and only in the presence of a high risk in the next move, which indicates a possible connection to anxiety.

Prof. Hendler summarizes: “Throughout life, we ​​learn to balance the fear of risking loss with the pursuit of profit, and we learn what is a reasonable risk to take in relation to the gain based on previous experiences. The balance between these two tendencies is a personality trait but is also affected by stress (like the current pandemic). A disorder in this trait increase sensitivity to stress and can cause non-adaptive behavior such as a high propensity for risk-taking or excessive avoidance.

“Our research shows for the first time how the human brain is affected by the experience of failure or loss when it is our responsibility, and how this inclination produces avoidance behavior under particularly stressful uncertainty. An understanding of the neural mechanism involved may guide future neuropsychiatric therapies for disorders featuring excessive avoidance, such as depression, anxiety, and PTSD, or disorders associated with excessive risk-taking, such as addiction and mania.”

Featured image: Prof. Talma Hendler

Physical exercise can help improve both physical and mental health

Participating in online sports programs during the COVID-19 pandemic improves adolescents’ psychological resilience

Researchers at Tel Aviv University have examined the connection between adolescents’ mental resilience and their participation in sports programs during the coronavirus pandemic. The researchers found that adolescents who continued to work out in a group context during the lockdown were more mentally resilient than their peers – even though the practice sessions were conducted online. The study – the only one of its kind in the world to focus on adolescents – was conducted by Dr. Keren Constantini, Irit Marcus, Dr. Naomi Apple, Dr. Ronit Jakobovitch, Dr. Iftach Gafner and Dr. Shahar Lev-Ari, and its results were presented at a joint conference of the Schools of Public Health Organization, the Israel Association of Public Health Physicians and the Sports Physicians Association.

“We conducted the study during the general lockdown,” says Dr. Lev-Ari, Head of the Department of Health Promotion at Tel Aviv University. “Some organizations and gyms had suspended their sports programs, but others – like the educational sports organization Chamesh Etzbaot (Five Fingers), adopted an online format, mostly through Zoom. We were interested in checking whether online activities helped build adolescents’ physical and mental resilience. To do this we compared two groups: adolescents who continued to practice in an online group context, and their peers who exercised on their own during the lockdown.”

For this purpose, Dr. Lev-Ari and his team conducted an online survey designed to test resilience levels, health behaviors and risk perceptions of 473 adolescents who had been enrolled in organized sports programs before the coronavirus outbreak. Their findings were statistically significant: Adolescents who continued to participate in sports programs through an online format during the lockdown actually practiced more, and consequently exhibited higher levels of resilience, had better self-esteem and higher morale, and expressed fewer concerns about the pandemic.

“We found that adolescents who continued to take part in their sports programs through the internet practiced more – 242 minutes of practice per week vs. only 191 minutes for adolescents who worked out on their own,” explains Dr. Lev-Ari. “But this only accounts for the physical resilience. In addition, there is the aspect of mental resilience: a person’s ability to cope with difficulties, burdens and stress. This has to do with an element of personal endurance that stems from personality, as well as various acquired elements – like the size of the ‘battery’ I have for withstanding pressure, and how quickly I can recharge it.”

To test the adolescents’ mental resilience, the researchers compared the results of those who practiced in an online group with the results of those who continued to work out on their own during the lockdown, based on validated questionnaires such as the Connor-Davidson Resilience Scale.  These questionnaires include statements like “I tend to bounce back easily from illness or difficulty”, “I don’t despair easily when I fail” and “I see the amusing side of things” – with each respondent ranking how true the statement is for him/her on the given scale.

“The results were unequivocal, in all measures,” says Dr. Lev-Ari. “The adolescents who continued their sports program exhibited higher spirits, less anxiety about themselves and their families, and  lower levels of stress – even though their practice sessions continued through Zoom. Moreover, these adolescents were more aware of the importance of organized sports, especially at this time. 84% of the adolescents who participated in sports said that the continued practice sessions helped them cope with negative feelings and low spirits during the lockdown; 55% indicated that their contact with the coach served as a meaningful source of support. Our study proves the importance of continued activities in organized sports programs in these challenging times of the COVID-19 pandemic, and similar conclusions can certainly be deduced with regard to other social organizations as well, such as youth movements.”

Pharmaceutical residuals pose a serious threat to Marine life

A study by Tel Aviv University reveals worrying evidence of environmental contamination

A study led by Prof. Noa Shenkar and graduate student Gal Navon, from the Tel Aviv University (TAU) School of Zoology and the Steinhardt Museum of Natural History, has found significant concentrations of residual pharmaceuticals at 11 sampled sites along the Israeli coastline. These substances have been found in ascidians – marine, filter-feeding, sessile invertebrates. This study was conducted with the participation of the Hydrochemistry Lab of the Water Research Center of the Porter School of the Environment and Earth Sciences, Raymond & Beverly Sackler Faculty of Exact Sciences, Tel Aviv University, headed by Prof. Dror Avisar. The study was published in the journal “Marine Pollution Bulletin”, in August 2020. The study involved sampling of ascidians from 9 different sites along the Mediterranean coastline (Achziv, Acre, Haifa Marina, Sdot Yam, Hadera power station, Acadia beach in Herzliya, HaSela beach in Bat-Yam, Ashdod Marina and Ashkelon Marina) and 2 different Red Sea sites (Eilat Marina and Dolphin Reef). Ascidians are marine invertebrates, few centimetres in size that attach to hard surfaces – such as rocks, peers or breakwaters. Since ascidians feed on small particles found in the water, large quantities of particles from the marine environment accumulate in their bodies over time – including different pollutants. The researchers have performed chemical analysis of the collected ascidians, searching for active compounds of three frequently used pharmaceuticals: Bezafibrate, which reduces blood lipids content; Carbamazepine, an antiepileptic, and mood stabilizer; and Diclofenac, an anti-inflammatory agent present in the well-known medicine Voltaren. These three substances are extremely durable, are hardly degraded by sewage treatment facilities, and last long in the marine environment. The findings are extremely worrisome: in 10 out of 11 sampled sites significant concentrations of the tested pharmaceuticals have been found.
  • All three substances have been detected at 4 of the tested sites (Ashdod, Ashkelon, Sdot Yam and Haifa).
  • Residuals of two of the pharmaceuticals have been detected at 5 of the tested sites (Achziv, Acre, Herzliya, Bat-Yam and the Eilat Marina).
  • One site – Eilat Dolphin Reef, has shown signs of one pharmaceutical only – Diclofenac, though at a concerning concentration
  • Ascidians collected from deep water at the Hadera power station were the only ones to show no traces of pharmaceuticals.
  • Especially high concentrations of Diclofenac and Bezafibrate were found in Acre, Ashdod and Ashkelon.
  Did they take their medicine today? Ascidians Prof. Shenkar and the researcher Gal Navon explain that various pharmaceuticals consumed by humans are not fully metabolized in the body, and high percentage of their active compounds are later excreted in their original form. In addition, lack of public awareness often results in the disposal of unused drugs in toilets or home garbage bins. Currently existing sewage treatment facilities are not suitable for the treatment of medication residuals, and, unlike other pollutants, their final concentrations at the endpoint of sewage treatment are not monitored. Eventually, a substantial amount of pharmaceuticals is discharged into the sea by sewage water. According to the research team, a variety of pharmaceutical residuals can be found in marine ecosystems worldwide – antibiotics, anti-inflammatory drugs, analgesics, anti-depressants and many more. “Many of these compounds are very stable”, the researchers say, “These take a long time to degrade in the marine environment, and the damage they cause to marine life could be extremely excessive, since these pharmaceuticals are designed to affect biological systems (the human body). For example, various studies performed in different sites around the world have shown that Estrogen, present in birth control pills, leads to the development of female features in male fish in certain species, thus damaging their fertility; Prozac triggers increased aggressiveness and risk-taking in crustaceans; anti-depressants impair memory and learning in cuttlefish, and more”. Prof. Avisar: “We have been studying the chemo-physical fate of drug residuals in groundwater and surface water for the past 15 years, and their detection in marine ecosystems has been surprising. The results indicate a chronic large-scale pharmaceutical residuals contamination, as well as the absorption of micro- and nano-pollutants, measured at very low concentrations in marine organisms”. “Our study shows that Israel is no stranger to the global serious issue of seawater pharmaceutical contamination.”, Prof. Shenkar concludes. “The medications we use end up in the sea, mainly through sewage discharge, and cause great damage to the marine environment, indirectly affecting humans, who feed on sea foods that are exposed to such contamination. There are different ways to tackle this problem: on the individual level, we recommend that the population as a whole takes personal responsibility, disposing of unused pharmaceuticals into designated containers – which can be found at pharmacies and health maintenance organizations’ facilities. In addition, we are working to expand research on monitoring pharmaceutical contamination along the Israeli coastline, using advanced analysis of a greater variety of widely used medication, while examining the changes exerted upon the various organisms exposed to the environmental concentrations of those pharmaceuticals”.

Tel Aviv University Researcher Heads a Committee in Charge of the Future of the European Science

CERN Council unanimously decided to update its scientific strategy – according to the recommendation of a committee headed by Prof. Halina Abramowicz

After two years of prolonged discussions of physicists from across Europe and outside the continent, the European Organization for Nuclear Research (CERN) decided lately to update its strategy, according to the recommendation of the European Strategy for Particle Physics Update Committee (EPPSU) – headed by Prof. Halina Abramowicz from Tel Aviv University.

Prof. Halina Abramowicz: “As the head of the committee I had to coordinate the effort in its whole. At the beginning of our work at the committee, we clarified the needs of the particle physicist’s scientific community in each country, and afterwards we conducted an international analysis of the proposals’ quality.  After two years of discussions, the European scientific community reached an agreement. Fortunately, CERN Council decided to endorse the committee’s recommendations. Those are heavy financial and political decisions that are made once in a decade, and it’s not every day that Israel finds itself heading a policy-outlining committee.”

The committee headed by Prof. Abramowicz set, in effect, the CERN strategy for the fourth decade of the 21st century, after the Large Hadron Collider (LHC) research program, world’s largest particle collider, would end. The committee decided that the European particle physics’ main goal would be an electron-positron collider which will be a “power house” for the Higgs Boson particle that was discovered for the first time at the LHC. It would be followed by a new, 62-mile-long, proton-proton collider that was proposed and which is expected to surpass the energy production records of the LHC. Its cost is estimated at 25 billion dollars.

The Higgs Boson particle was discovered at the LHC in 2012 and caused a revolution in particle physics. Not only is the Higgs Boson the last missing part in the standard particle model, but it also was proven to be completely different from any other particle previously measured. The research regarding the Higgs Boson is just taking its first steps, but the particle properties, such as its light weight, already raise profound questions that the standard model cannot explain. It is very hard to accurately measure the particle, also known as the god particle, and hopefully, the new approach, recommended by Prof. Abramowicz’s committee, will allow more accurate measurements of the Higgs Boson, thus paving the way for new insights about the basic fabric of the universe.

“We are trying to understand how the universe started and what it’s made of – this is basic science,” explains Prof. Abramowicz. “But, in order to understand this we need technological advances and developments, some of which are being implemented afterwards in other fields as well. For example, the PET CT, a medical tomography test used worldwide at medical centers, was developed due to projects similar to the LHC, as well as several significant developments in Big Data processing in the Cloud Computing field. In order to examine the feasibility of the new collider, CERN works these days on developing world first magnets which will use high temperature super conductors – a development which can cause a revolution in transportation, with floating magnet trains, and those are just a few examples. We don’t know which doors would be opened to us with this new challenge that the committee made CERN face – both in basic science and in collaboration with the industry, which will be needed to build the collider.”

To achieve the ambitious ESPPU goals, particle physicists are being called to execute vigorous research and development programs (R&D) of advanced collider technologies, particularly regarding high level and high temperature super conductors. In addition, the roadmap includes R&D of plasma wakefield acceleration, as well as an international research with the option of realising a muon collider and R&D of advanced detectors.

“Israel joined CERN as a full member in 2014, and is the first and only non-European country to join,” says Prof. Abramowicz, who takes part in the “ATLAS” experiment at the LHC. “It’s our national lab. Researchers from Tel Aviv University, the Ben-Gurion University, the Hebrew University, Technion – Israel Institute of Technology, and Weizmann Institute are senior partners running experiments at the LHC. Therefore, recommendations made by the EPPSU committee are important not only to science but also to our scientific community, technology, economy and our society. ”

Featured image: Prof. Halina Abramowicz

New school for Biomedicine and Cancer Research at Tel Aviv University

The school, funded by a generous endowment from the Shmunis Family, aims to research and improve treatments for cancer, COVID-19 and other diseases

Israel’s Minister of Science and Technology Yizhar Shay and TAU President Prof. Ariel Porat will attend the inauguration ceremony of the Shmunis School of Biomedicine and Cancer Research, to be held on Wednesday, August 12, 2020.

The School belongs to the George S. Faculty of Life Sciences and the generous donation will enable a leap in groundbreaking research. At the Shmunis School researchers will be able to identify mechanisms that drive cancer and other diseases, developing new pharmaceuticals and improving patients’ quality of life. This will be achieved through multidisciplinary collaborations and novel research approaches, such as single cell sequencing, proteomics, lipidomics and bioinformatics.

In addition, the new partnership will enable the University to recruit the finest researchers into its faculty, attract the best post-doctoral candidates, award the annual Shmunis Fellowships to exceptional PhD students, and more. The School will also collaborate with many leading academic institutions and host Shmunis Visiting Scholars and international conferences.

Create an important impact

Yizhar Shai, Israel’s Minister of Science and Technology: ”Tel Aviv University is one of the leading academic institutions in Israel and the inauguration of the Shmunis School of Biomedicine and Cancer Research proves that the university also made an international name for itself. Connections like that, between the academia and industry’s needs, create an important impact on academic institutions, the students passing through them, and the whole Israeli economy. I congratulate the Shmunis family for the most welcome donation which promotes cancer research. I have no doubt that the research and the developments from this institution will be Israel’s pride and joy.”

Prof. Ariel Porat, President of TAU: “I am grateful to the Shmunis family for their important and generous gift. The funds will enable researchers at the School to work at the forefront of global science and to develop insights leading to the development of new technologies and drugs in the battle against cancer and other serious diseases.”

Vlad and Sana Shmunis expressed the hope that the gift will help strengthen Israel’s standing as a global leader in cancer and molecular biomedical research. Vlad Shmunis: “My wife Sana and I are very happy that we can take part in supporting frontline research. Cancer is a disease that has unfortunately touched our family and far too many other families around the world.  We hope that our gift to TAU will significantly advance research and treatment of cancer and other serious diseases to improve the lives of people in Israel and around the world.”

Featured image: TAU President Prof. Ariel Porat and Israel’s Minister of Science and Technology Izhar Shay (Photo Credit: Chen Galili)

Fight Online Antisemitism

Kantor Center Joined 125 International Organizations in a Call to Adopt the International Definition of Antisemitism, In Light of the Covid-19 Pandemic and the Spike in Antisemitism on Social Networks

Kantor Center for the Study of Contemporary European Jewry at Tel Aviv University joined 125 international, Jewish and non-Jewish, organizations that published a joint call to social networks, including Facebook, to adopt the International Holocaust Remembrance Alliance (IHRA) Working Definition of Antisemitism in order to fight online antisemitism.

Despite the efforts that have been done, social networks haven’t officially adopted yet a clear policy regarding racism and antisemitism, which gives platform to numerous antisemitic posts in the name of the freedom of speech. It should be noted that up until now, around 40 countries and many organization adopted the Working Definition of Antisemitism.

According to the IHRA’s definition: “Antisemitism is a certain perception of Jews, which may be expressed as hatred toward Jews. Rhetorical and physical manifestations of antisemitism are directed toward Jewish or non-Jewish individuals and/or their property, toward Jewish community institutions and religious facilities.”

Prof. Dina Porat, Head of Kantor Center, who was among those who formulated the international definition, emphasizes that in the last few months, especially in light of the Covid-19 pandemic, there’s a spike in blatant antisemitic statements on social networks worldwide. According to her, most of the incitement on social networks comes from extremist organizations, which turn the ‘freedom of speech’ to ‘freedom of incitement’. “We see antisemitic expressions even among young people who post offensive posts on social networks and spread them to various user communities worldwide. Unfortunately, social networks that do not block or remove offensive posts, are giving a platform to those dangerous sayings, even without meaning it.”

Prof. Port adds: “The IHRA Definition has become a yard stick, a declaration of values: Those who join its adoption are committed to countering of antisemitism, and of other parallel evils. It’s high time that the major social networks, Facebook first and foremost, use the IHRA definition as a criteria to identify antisemitic expressions, and uproot them immediately, thus exercising their responsibility to help create a world better than the one we are living in.”

TAU Researcher Invents Environmentally-Friendly Sanitizer

Innovative method to convert waste into disinfectant is a pandemic game-changer

The fight against coronavirus began with disinfection and hygiene. Prof. Hadas Mamane, head of the Water-Tech Laboratory at TAU’s Iby & Aladar Fleischman Faculty of Engineering is now helping to secure Israel’s sanitizer supply in the ongoing battle against the spread of coronavirus. Her lab is running a pilot program to convert local waste into alcohol that will be used for sanitation and disinfection. In the COVID-19 era, global demand for alcohol-based sanitizer soared, as proper hygiene and sanitation became mainstays of prevention efforts. Yet at the same time, many countries, including Israel, imposed import restrictions, making the procurement of sanitation and disinfectant materials difficult. To address this shortage, a team led Prof. Mamane adapted an existing waste conversion model to produce alcohol disinfectant locally. Prof. Mamane’s team began by running an experiment to make ethanol, an alcohol derived from corn and the most common ingredient in hand sanitizers and other disinfectants. As a local alternative to corn, Prof. Mamane checked a variety of waste sources. She experimented with waste from municipal and agricultural pruning, hay, paper and cardboard. Prof. Mamane is continuing the project by using more types of green waste, testing the process on a larger scale and studying its cost-effectiveness. Because her method relies on locally sourced material, it offers a decentralized model for ethanol production that reduces reliance on imports. Mamane’s production method not only reuses the almost endless supply of garbage, but also reduces overload on waste management systems. The process does not use hazardous materials or cause pollution, can be applied on a small or large scale, and is applicable to varied types and large amounts of waste. This initiative has additional widespread benefits: “A decentralized [recycling] process enables farmers to avoid burning their agricultural waste, and instead offers environmental and social benefits to the community and, most importantly, protects public health,” says Prof. Mamane. This research is a collaboration between Prof. Mamane and the University of Haifa-Oranim College, and is funded by the Ministry of Science. Featured image: Prof. Hadas Mamane (Credit: Vered Cohen-Yaniv)

Victoria

Tok Corporate Centre, Level 1,
459 Toorak Road, Toorak VIC 3142
Phone: +61 3 9296 2065
Email: [email protected]

New South Wales

Level 22, Westfield Tower 2, 101 Grafton Street, Bondi Junction NSW 2022
Phone: +61 418 465 556
Email: [email protected]

Western Australia

P O Box 36, Claremont,
WA  6010
Phone: :+61 411 223 550
Email: [email protected]